George Ellis has been President and CEO of HealthWest since its inception in 2007. With HealthWest, Mr. Ellis has provided drug and alcohol regulatory compliance consulting services to the public and private sectors, including for the Federal Railroad Administration and previously for the U.S. Department of Interior. He also currently manages forensic toxicology consultation contracts with both the Federal Railroad Administration and the U.S. Department of Defense. Mr. Ellis has over 35 years of service in the drug and alcohol abuse field. He has extensive experience in all scientific, technical, and policy areas affecting workplace drug and alcohol programs.
From 2007 to 2014, Mr. Ellis was also Executive Vice President for Occupational Health Services for Verifications Inc. (VI), a national employment and background screening services company headquartered in Minneapolis MN. Mr. Ellis was responsible for supporting drug and alcohol workplace testing and occupational health services for VI clients, including both Fortune 500 and Fortune 100 companies.
From 2004 to 2007, Mr. Ellis was a Senior Policy Advisor with the Office of Drug and Alcohol Policy and Compliance (ODAPC), Office of the Secretary of Transportation, Washington DC. As part of that position, Mr. Ellis helped establish policy, procedures, and regulatory guidance which governed the Federally mandated drug and alcohol testing of over 8 million employees working for over 650 thousand regulated employers.
From 1989 to 2003, Mr. Ellis was President and CEO of Greystone Health Sciences Corporation of La Mesa CA. In 2003, Greystone was acquired by First Advantage Corporation of St. Petersburg FL, where Mr. Ellis remained as a Vice President in their Occupational Health Services Group until his appointment to ODAPC. Greystone provided national drug and alcohol testing services in the areas of the medical review of drug and alcohol testing results, forensic toxicology consultation, company and agency policies, and compliance support services for employers falling under Federal, State, or company policy testing authority. Greystone clients included both Fortune 50 and Fortune 500 companies and a number of Federal and other public agencies (including the Federal Railroad Administration, the U.S. Department of Interior, and the U.S. Department of Defense).
For nine years, Mr. Ellis was involved in the treatment of over 10,000 drug and alcohol dependent Navy, Marine Corps, Coast Guard, Army, and Air Force service members at the U.S. Navy’s then single worldwide residential treatment facility for drug dependency. He left as Director of Treatment of that 210 bed residential facility.
Mr. Ellis has been an invited speaker at numerous professional and scientific conferences relating to topics in the drug and alcohol field. His writings have been published in a variety of settings, including the scientific journal Clinical Pharmacology and Therapeutics, the proceedings of the Transportation Research Board of the National Academy of Sciences, and the proceedings of the California Association of Toxicologists.